Navigation Links
Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels
Date:9/15/2008

ROCKVILLE, Md., Sept. 15 /PRNewswire-USNewswire/ -- Pre-mixed insulin analogues, a modified form of conventional pre-mixed human insulin, are more effective than long-acting analogues for controlling high blood sugar levels after meals in patients with type 2 diabetes, according to a report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

Conventional pre-mixed human insulin, however, appears to be equally effective as pre-mixed insulin analogues for lowering blood sugar levels when patients go eight or more hours without eating, according to the report. A version of the analysis is available on-line in the Annals of Internal Medicine.

Type 2 diabetes accounts for more than 90 percent of diabetes. The number of Americans diagnosed with type 2 diabetes tripled from 5.6 million in 1980 to 15.8 million in 2005. Obesity increases the risks of developing type 2 diabetes. Diabetes can cause serious problems with the heart, kidneys, eyes and nerves. Many patients with type 2 diabetes control their blood sugar through diet and use of oral medications. Recent research suggests that good blood glucose control can reduce loss of sight, kidney failure, and heart disease.

The new report was compiled by the Johns Hopkins University Evidence-based Practice Center in Baltimore, one of 14 such centers that are funded by AHRQ through its Effective Health Care program. The report represents a systematic review of 45 research studies and is intended to provide unbiased, evidence-based information so that patients, clinicians and others can make the best possible treatment decisions.

"While it is clear that pre-mixed insulin analogues offer certain advantages to patients with diabetes, what is good for one patient may not be good for another," said AHRQ Director Carolyn M. Clancy, M.D. "This report offers an important reminder that patients with diabetes should review their treatment pl
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
2. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
7. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
8. Treatment Corrects Severe Insulin Imbalance in Animal Studies
9. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
10. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
11. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswi...ed the completion of a Phase I study of CPSI-2364,...e production of TNF-alpha and other pro-inflammato...ity dose escalation study in healthy volunteers co...cal testing. ,, All 30 enrolled subjects comp...
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNewswir..., the global authority on medical technology marke...ial injectable market declined by almost 5% over 2... as a result of the economic crisis. The market wi...will return to the strong pre-recession growth rat...
(Date:11/30/2009)..., , ATLANTA, Nov. 30 Amoe...urgery breast care products, is sponsoring the 4th...or the first time, Amoena will honor survivors and... by awarding a cabin for the one with the most ins...test, Amoena wants to hear about young mothers who...
Breaking Medicine Technology:Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 1TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 2TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 3TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 4Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 1Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 2Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 3URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 1URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 2
...nte Carlo brings predictability to whole range ...s, WAYLAND, Mass., Sept. 4 Tourtellotte Solution...ply chain software for the,biopharmaceutical, reta...,the release of its tcVisualize(TM) 3.0 clinical t...ualize software now offers wide support for variab...
...itional very late stent thrombosis, NATICK, Mass....orporation (NYSE: BSX ) today announced five-year...l, demonstrating continued,long-term safety and ef...ystem. Among the findings, the TAXUS stent showed ...and five, while the bare-metal control,experienced...
Other Medicine Technology:Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 3Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4
(Date:11/30/2009)...ease Control and Prevention estimate that well ove...cted with HIV/AIDS. New research from North Caroli...ted are minorities and do not have health insuranc... to facilitate education and prevention efforts in...arch, which analyzed 90,000 HIV patient hospital v...
(Date:11/30/2009)...Author of "My Two-Year Old Eats Octopus,"...e to eat everything. , (P...er in your house? Do you find yourself acting as ...nline videos – one focusing on packing lunch...wers for real-life parents’ questions &ndash...
(Date:11/30/2009)..., Colo., Nov. 30 Baxa Corporation ...ng what "culture of safety" means in today,s pharm...n, "Creating a Culture of Safety in Pharmacy ," f...cussing their experiences with culture of safety, ...macy and the role of technology in enabling or inh...
(Date:11/30/2009)...h., Nov. 30 Stryker Corp...e agreement to acquire privately held Ascent Heal...processing and remanufacturing of medical devices ...t, Stryker will acquire Ascent Healthcare Solution... closing is conditioned on the expiration or termi...
(Date:11/30/2009)...d treating a tumor without disturbing normal tissu...e therapies can be invasive and harsh. , Researc...d a way they might deliver the right therapy direc...mers, which specifically bind to living tumor tiss...a rodent with liver cancer until they found the be...
Breaking Medicine News(10 mins):Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...er Orthopedic Group, Inc. announced today that Vin...e Vice President and Chief Growth Officer, effecti... Chief Executive Officer Thomas F. Kirk, Asar will...ching new businesses consistent with the company,s...
...d Corporation (Rite Aid) and nine of its subsidiar...in civil penalties to settle allegations of violat...epartment of Justice announced today. , , In add...to ensure compliance with all requirements of the ...
...ide relief from neuropathic pain , The pain that...ed by the trauma of amputation, entrapment, and co... extremely debilitating, and treatments show limit...ibutors to the pain. However, Halina Machelska and...
...immer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) anno...p;T,Corporation executive, has been appointed to i... serves on the boards of three other publicly trad...y regulated,markets," said John L. McGoldrick, Cha...
...Unite Americans in Fighting the Country,s Most Com...s Foundation today announces the launch of Let,s ...mprove the quality of life of the one-in-five Amer...s Move Together is designed to inspire people to ...
...eotaxis, Inc.,(Nasdaq: STXS ) today announced th...g the RF PowerAssert(TM) Magnetic Guidewire. Clea...08, the RF PowerAssert guidewire is the only,magne...ve solution that enables precise intra-lesion cont...
Other Medicine News:Health News:Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 2Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 3Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 2Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 3Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 2Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 3